Prognostic Factors after Liver Resection for Colorectal Liver Metastasis
- PMID: 26421789
- DOI: 10.20344/amp.4816
Prognostic Factors after Liver Resection for Colorectal Liver Metastasis
Abstract
Introduction: Surgery is the only potentially curative treatment for patients with colorectal liver metastases, resulting in 5-year survival rates of 36 - 58. Although many studies have been performed to determine prognostic factors for tumor recurrence and survival after resection of colorectal liver metastases, there are few prognostic scoring systems stratifying patients undergoing surgery for colorectal liver metastases into risk group models.
Objectives: To identify, evaluate and compare the existing prognostic scores for survival after surgery for resection of colorectal liver metastases.
Material and methods: Electronic search in PubMed, Cochrane and Embase from 1990 to 2013 using the terms 'hepatic resection', 'colorectal cancer', 'liver metastasis', 'hepatectomy', 'prognostic', and 'score'. Only studies proposing a prognostic model or risk stratification based on clinical and/or pathological variables were included.
Results: From 1996 to June 2013, 19 scoring systems were identified, including one nomogram. Thirty prognostic factors were identified although none of the factors was common to all prognostic models. The 4 factors most often included were: number of liver metastases, regional lymph node metastization of primary tumor, preoperative CEA level and maximum size of metastases. The median study sample size was 305 patients (81-1 568 patients) and median follow-up was 33 months (16-54 months). All studies were retrospective and used the Cox proportional hazards model for multi-variable analysis.
Conclusion: Several factors have been constantly reported as having prognostic value after liver resection of colorectal livermetastases, although there is no consensus on the ideal scoring system.
Introdução: A ressecção de metástases hepáticas é o único tratamento potencialmente curativo em doentes com metástases hepáticas de cancro colo-rectal, resultando numa sobrevida global de 36-58%. Até à data foram publicados múltiplos trabalhos sobre factores de prognóstico após hepatectomia em doentes com metástases hepáticas de cancro colo-rectal. No entanto, poucos apresentaram modelos de prognóstico que permitam estratificar os doentes em grupos de risco, relacionando-os com sobrevida após metastasectomia hepática.Objectivos: Identificar, avaliar e comparar os diferentes scores de prognóstico após recessão de metástases hepáticas de cancro colo-rectal.Material e Métodos: Pesquisa na PubMed, Cochrane e Embase, de artigos publicados entre 1990 e 2013, usando os termos ârecessão hepáticaâ, âcancro colo-rectalâ, âmetástases hepáticasâ, âhepatectomiaâ, âprognósticoâ e âmodeloâ. Apenas os artigos que apresentaram modelos de prognóstico com base em variáveis clínico-patológicas foram incluídos.Resultados: De 1996 a Junho de 2013, 19 modelos de prognóstico foram identificados, incluindo um nomograma. Foram identificados 30 diferentes factores prognósticos, embora nenhum factor fosse comum a todos os modelos prognósticos. Os factores mais frequentemente incluídos foram: número de metástases hepáticas, envolvimento ganglionar regional do tumor primário, nível sérico de CEA pré-operatório e tamanho máximo das metástases. A amostra mediana foi de 305 doentes (81-1 568 doentes) e o seguimento mediano foi de 33 meses (16-54 meses). Todos os estudos foram retrospectivos e utilizaram o modelo proporcional de Cox para análise multivariada.Conclusão: Vários factores têm sido constantemente reportados como tendo valor prognostico após ressecção de metástases hepáticas de cancro colorectal, no entanto, não existe consenso sobre o modelo ideal de prognóstico.
Similar articles
-
Individual data meta-analysis for the study of survival after pulmonary metastasectomy in colorectal cancer patients: A history of resected liver metastases worsens the prognosis.Eur J Surg Oncol. 2018 Jul;44(7):1006-1012. doi: 10.1016/j.ejso.2018.03.011. Epub 2018 Mar 21. Eur J Surg Oncol. 2018. PMID: 29602524
-
Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.World J Surg Oncol. 2015 Mar 4;13:92. doi: 10.1186/s12957-015-0497-6. World J Surg Oncol. 2015. PMID: 25889950 Free PMC article.
-
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].Chir Ital. 2005 Sep-Oct;57(5):555-70. Chir Ital. 2005. PMID: 16241086 Italian.
-
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise?HPB (Oxford). 2010 May;12(4):227-38. doi: 10.1111/j.1477-2574.2010.00158.x. HPB (Oxford). 2010. PMID: 20590892 Free PMC article. Review.
-
[Surgical treatment of colorectal liver metastasis].Nihon Geka Gakkai Zasshi. 2003 Oct;104(10):721-9. Nihon Geka Gakkai Zasshi. 2003. PMID: 14579759 Review. Japanese.
Cited by
-
FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.Int J Clin Oncol. 2020 Feb;25(2):322-329. doi: 10.1007/s10147-019-01557-0. Epub 2019 Oct 14. Int J Clin Oncol. 2020. PMID: 31612350
-
A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases.Eur J Cancer. 2022 Mar;163:66-76. doi: 10.1016/j.ejca.2021.12.013. Epub 2022 Jan 14. Eur J Cancer. 2022. PMID: 35042069 Free PMC article.
-
Establishment and validation of predictive models by mutational and transcriptional factors for the prognosis of stage IV colorectal cancer patients with liver metastasis who undergo palliative surgery on primary tumors.Transl Cancer Res. 2025 Jan 31;14(1):225-239. doi: 10.21037/tcr-24-1183. Epub 2025 Jan 21. Transl Cancer Res. 2025. PMID: 39974400 Free PMC article.
-
Gamma-glutamyl transferase to aspartate aminotransferase ratio (GSR) predicts prognoses in patients with colorectal cancer with liver metastasis after microwave ablation.BMC Gastroenterol. 2024 Sep 30;24(1):327. doi: 10.1186/s12876-024-03419-0. BMC Gastroenterol. 2024. PMID: 39350076 Free PMC article.
-
Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation.Oncologist. 2020 Jul;25(7):e1031-e1041. doi: 10.1634/theoncologist.2019-0797. Epub 2020 Mar 17. Oncologist. 2020. PMID: 32181531 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical